This technology is a method for synthesizing nucleic acids and other biopolymers without the use of a template. More specifically, this method is a highly parallel enzymatic synthesis of biopolymers on a microfluidic device. This technology has implications in DNA-based memory and RNA and DNA-based vaccine products.
- Disclose & Protect Your Intellectual Property
- Learn About Intellectual Property
- Explore MIT Technologies
- Trademark & Merchandise
- Engage with the TLO